title: Periocular Scleromyxedema.
abstract: Scleromyxedema is characterized by cutaneous mucinosis and rarely presents to oculoplastic surgeons with bilateral upper and lower eyelid swelling. The authors present 2 case reports with a review of the literature and discuss the ophthalmic manifestations of scleromyxedema and the management of these cases. Both patients were in their early 50s and were fit and well prior to the presentation. They both presented with eyelid swelling and underlying nodularity of the subcutaneous tissue. The skin biopsy confirmed cutaneous manifestations of scleromyxedema. The systemic manifestations responded to intravenous and oral steroids and intravenous infusions of immunoglobulin. The ophthalmic manifestations were managed conservatively. Scleromyxedema is a rare connective tissue disease characterized by cutaneous mucinosis, extracutaneous manifestations, and monoclonal gammopathy. It rarely affects the eyelids and cornea. The authors would like to present 2 cases of periocular scleromyxedema.
authors.affiliation: Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester, United Kingdom.
authors.forename: Farhan
authors.initials: F
authors.lastname: Qureshi
authors.forename: Aruna
authors.initials: A
authors.lastname: Dharmasena
authors.forename: Brian
authors.initials: B
authors.lastname: Leatherbarrow
mesh_terms: D000284:Administration, Oral; D005141:Eyelid Diseases / Q000188:drug therapy / Q000473:pathology*; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D053718:Scleromyxedema / Q000188:drug therapy / Q000473:pathology*
chemical_list: D005938:Glucocorticoids; D011239:Prednisolone